UNSPSC 85522160: Bypass left subclavian vein to upper vein with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass left subclavian vein to upper vein with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 051647Y

UNSPSC 85522160 Bypass left subclavian vein to upper vein with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code. The source shows minimal recent state and local procurement activity aligned with this specific surgical procedure code; recent opportunities tagged under this code address medical staffing, occupational health surveillance, pharmacy benefit management, and behavioral-health services for youth in custody—none of which involve vascular surgery or tissue-substitute implantation. The code appears to be a medical taxonomy entry with little to no matching state and local procurement volume.

The source records six recent state and local solicitations nominally tagged under this code, but only one—the Washington State Department of Transportation's occupational medical surveillance RFP (due October 9, 2026)—involves a licensed physician performing clinical evaluations. The City of Phoenix Retirement Office's independent medical evaluation RFP (due October 16, 2026) seeks medical record summary and disability examination coordination rather than surgical procedures. The City of Long Beach's surgery-benefit carve-out program (due October 7, 2026) references surgical procedures but procures network management and bundled payment administration, not surgical implants or vascular interventions. The remaining three opportunities cover pharmacy benefit management, temporary clinical staffing, and inpatient care for detained youth. Geographic activity spans Arizona, California, Florida, and Washington; no pattern of repeat buyers under this code emerges from the recent record. If your firm pursues vascular-surgery supplies or tissue-substitute devices, this code's current procurement signal is negligible; state and local bodies tagging opportunities here appear to be using mismatched taxonomy rather than sourcing the procedure or device the code describes.